Collagens constitute a major portion of the extracellular matrix in the atherosclerotic plaque, where they contribute to the strength and integrity of the fibrous cap, and also modulate cellular responses via specific receptors and signaling pathways. This review focuses on the diverse roles that collagens play in atherosclerosis; regulating the infiltration and differentiation of smooth muscle cells and macrophages; controlling matrix remodeling through feedback signaling to proteinases; and influencing the development of atherosclerotic complications such as plaque rupture, aneurysm formation and calcification. Expanding our understanding of the pathways involved in cell-matrix interactions will provide new therapeutic targets and strategies for the diagnosis and treatment of atherosclerosis.
Introduction
The arterial wall is composed of a highly ordered structure of cells and extracellular matrix (ECM). In the intimal layer, endothelial cells sit upon a basement membrane rich in laminin, fibronectin and type IV collagen. In the media, individual smooth muscle cells (SMCs) are surrounded by a basement membrane, and are in turn embedded in fibrillar types I, III and V collagen, type XVIII collagen, fibronectin and proteoglycans. In elastic arteries, each layer of SMCs is separated by a well-defined, fenestrated elastic lamina. The outermost layer, the adventitia, is rich in fibroblasts, collagen types I and III and elastin. After arterial injury and during atherosclerotic plaque development, there are pronounced changes in the composition of the ECM. The schematic diagram shown in Figure 1 depicts critical events that stem from the interaction between collagen and SMCs during atherogenesis. SMCs transition from a contractile to a synthetic phenotype and begin to deposit types I and III collagen, elastin and fibronectin. They also synthesize different ECM molecules seen only in small quantities in normal vessels, including type VIII collagen, osteopontin and tenascin. In addition to enhanced and altered ECM synthesis, degradation of the matrix is also enhanced during atherogenesis due to increased activity of proteinases including the matrix metalloproteinase (MMP), cathepsin and plasminogen activator/plasmin families. This combination of ECM synthesis and degradation, matrix remodeling, can also leave behind bioactive fragments, including fragments of types I and IV collagen and elastin, each of which may have effects on target cells distinct from that of the intact molecule.
In this review, we will summarize recent literature reporting on collagen remodeling in vascular pathologies such as atherosclerosis and restenosis. In the first section ('Collagen remodeling, SMC proliferation and migration'), we provide an overview of how new collagen synthesis and collagen turnover impacts upon the migration and proliferation of the resident vascular wall SMCs. In the following section ('Collagen regulation of inflammatory cells in atherosclerosis'), we examine the growing literature on the effects of collagen-induced signaling in inflammatory cells, and highlight areas which are in need of further investigation. Finally, in the last section ('Collagens and atherosclerotic complications'), we outline the critical roles that collagens and collagen degradation play in atherosclerotic complications such as plaque rupture, aneurysm formation and intimal calcification.
Collagen remodeling, smooth muscle cell proliferation and migration
During the progression of atherosclerosis, SMCs undergo a transition from a quiescent, contractile phenotype to a proliferative, matrix synthetic phenotype. 1 The accumulation of collagen is very significant and it is estimated that collagens comprise 60% of the protein in the plaque. 2 The collagens elaborated by SMCs feed back through receptor-mediated signaling to influence cell phenotype and behavior. The principle collagen binding receptors expressed on SMCs include integrins (α 1 β 1 , α 2 β 1 and α 10 β 1 ) and the discoidin domain receptor tyrosine kinases (DDR1 and DDR2). The integrins bind to defined amino acid sequences on fibrillar collagen molecules (GFOGER, GLOGER, and GASGER sequences). 3 The α v β 3 integrin can bind to the RGD sequences exposed on denatured or fragmented collagen in vitro, but it is not known to what extent this binding occurs in vivo. 4 The DDRs are receptor tyrosine kinases which bind to multiple collagens including types I-VI, VIII and X. 5, 6 DDRs are present on the cell membrane and bind to triple helical collagen molecules as preformed dimers. [7] [8] [9] The NMR structure of the discoidin domain of DDR2 has been solved, 10 and the minimal hexapeptide required for DDR2-mediated binding to collagen types I-III was determined to be GVMGFO. 11 These studies also provided a structural basis for the specificity of DDRs for triple helical collagens as opposed to denatured collagen or gelatin. 11 The exact ligand binding site of DDR1 remains elusive but studies using atomic force to the synthetic phenotype, and begin to synthesize ECM, which influences cell proliferation and migration (e.g. type VIII collagen). The cells also modify the ECM by producing MMPs which release cryptic fragments that can stimulate cellular responses. (C) Intimal calcification is a feature of advanced plaques, and is cell-dependent. The changing ECM may drive the phenotypic transition of resident cells, or the recruitment of circulating cells as illustrated, though the mechanisms are not completely understood.
microscopy suggest that DDR1 oligomers bind to overlapping collagen monomers simultaneously. 12, 13 Cell proliferation SMC proliferation makes an important contribution to the growth of the atherosclerotic plaque, and type I collagen is a critical regulator of proliferation. Koyama and colleagues found that plating SMCs on top of polymerized two dimensional (2-D) type I collagen maintained SMC quiescence by upregulating the cyclin-dependent kinase inhibitors p27 Kip1 and p21 Cip1 . 14 Suspending SMCs within a polymerized three dimensional (3-D) type I collagen gel also resulted in growth suppression mediated by p21 Cip1 . 15 Studies by Tanner and colleagues have provided in vivo confirmation of the anti-proliferative effects of polymerized fibrillar type I collagen. Following injury of the pig coronary artery, p27 Kip1 levels were first downregulated during early SMC proliferation, but later upregulated in parallel with increased collagen deposition in the vessel wall. 16 By contrast, plating SMCs on monomeric type I collagen 14 or treating SMCs with soluble type I collagen added to the culture mediastimulated cell proliferation, 17 with the latter activating phospholipase C (PLC) and PI3K pathways. Furthermore, soluble type I collagen and plateletderived growth factor (PDGF-BB) act synergistically to increase cell proliferation via receptor cross-talk between the PDGFRβ and the α 2 β 1 integrin. 18 Type VIII collagen is a short chain collagen produced in abundance after vascular injury and during atherosclerosis by SMCs and macrophages within the lesions. [19] [20] [21] [22] [23] [24] Adhesion of SMCs to type VIII collagen is mediated by DDR 25 and the α 2 β 1 and α 1 β 1 integrin receptors. 26 Studies from our laboratory comparing SMCs derived from wild-type or type VIII collagen-deficient mice indicate that wild-type cells produce type VIII collagen and use it to mask type I collagen, thereby allowing the cells to proliferate even in the presence of polymerized type I collagen. 27 These studies show that different types of collagen and the physical conformation of the collagen can have very different effects on SMC proliferative responses.
Studies of atherosclerotic coronary arteries from diabetic patients have uncovered increased expression of the mRNAs for types I and III collagen correlated with markers of cell proliferation including Cdks and cyclins. 28 These results are interesting because compared to non-diabetic patients with atherosclerosis, diabetics experience marked enhancement of vascular collagen accumulation, modification of collagens by advanced glycation end products, and an increased incidence of resteno-sis. Thus, collagen remodeling may be linked to the increased severity of disease in diabetics.
The collagen-binding DDRs are expressed in the atherosclerotic plaques of non-human primates 29 and recent research shows that the DDR1 can control SMC responses to injury. Using DDR1-null mice, we determined that DDR1 played a critical role mediating neointimal hyperplasia after arterial injury. 25 Furthermore, Ddr1 -/-SMCs exhibited reduced proliferation, migration, and MMP activity in response to type I or type VIII collagen in vitro, 25 and overexpression of DDR1 rescued these deficits. 30 In agreement with this, overexpression of DDR1 or DDR2 in human SMCs increased MMP-1 expression and decreased procollagen α 1 (I) mRNA expression. 29 Recent studies from our laboratory have demonstrated that SMC responses to collagen mediated by DDR1 may depend upon the disease context and the experimental model used. Studying a mouse model of atherosclerosis (the low-density lipoprotein receptor (LDLR)-deficient mouse fed a highfat diet), we determined that there was no alteration in SMC accumulation in atherosclerotic lesions in Ddr1 -/-;Ldlr -/compared to Ddr1 +/+ ;Ldlr -/mice. However, there was a decrease in lesion size, decreased macrophage accumulation, and an early dramatic acceleration of ECM synthesis by SMCs. 31 Therefore, in the context of a complicated model of atherosclerosis, the DDR1 is not critical for SMC infiltration of the plaque, but does influence matrix synthesis and accumulation by SMCs.
Cell migration SMC migration from the media into the intima contributes to the expansion of the atherosclerotic plaque. Migration is a multi-step process, consisting of adhesion, spreading, and translocation of the SMCs, and each step can be influenced by molecules in the ECM. SMCs were able to migrate on type I collagen in vitro, 32, 33 and the polymerization state of collagen influenced migration speed such that SMCs plated on monomeric collagen moved faster than those on polymerized collagen. 14 SMC attachment was similar, but cell spreading and the number of focal adhesions formed were greater on the monomeric collagen substrate. Further studies showed that plating SMCs on polymerized type I collagen suppressed the expression of many genes, including actin binding proteins known to be important in the regulation of cell spreading. 34 Consistent with the above studies, suspending SMCs within polymerized 3-D type I collagen gels suppressed the formation of actin stress fibers and focal adhesions, and decreased the phosphorylation of focal adhesion kinase. 15 Taken together these studies support the notion that polymerized type I collagen inhibits SMC migration.
In the basement membrane, type IV collagen likely serves to maintain SMC quiescence. Type IV collagen expression is higher in SMCs of the quiescent contractile phenotype compared to activated proliferating and migrating SMCs. 35 In fact, stimulation with PDGF-BB, which stimulates SMC proliferation and migration, decreased type IV collagen synthesis. 36 However, another study showed that soluble type IV collagen added to the media stimulated the migration of SMCs in vitro, 17 indicating that cell responses to this molecule might be dependent upon the context in which the cells are exposed to collagen (i.e. assembled in the basement membrane versus solubilized in the media). Furthermore, another study argued that SMC chemotaxis and haptotaxis towards type IV collagen was equal to or greater than that to type I collagen. 37 Thus, it is increasingly clear that cellular responses are governed not only by the type of collagen to which the cells are exposed, but also the concentration, conformation and context of the collagen molecules within the ECM.
Studies have shown that SMCs must degrade type I collagen in order to move across or invade through 3-D collagen gels. 38, 39 Proteolysis gives rise to collagen fragments which can influence the behavior of SMCs. Bacterial collagenase-degraded collagen fragments induce the rapid disassembly of focal adhesion complexes in SMCs, facilitating release from the matrix and cell migration. 40 Type I collagen degradation also acts indirectly to stimulate SMC migration and proliferation by upregulating another ECM molecule, tenascin-C. Collagen fragments signal via the α v β 3 integrin receptor to activate ERK1/2-dependent tenascin-C production, and tenascin-C in turn stimulates SMC proliferation and migration. 41 SMCs plated on degraded collagen fragments also had higher levels of RhoA and Rho kinase (ROCK) activity, which allowed for cell spreading and F-actin stress fiber formation, and resulted in the increased production of tenascin-C. 42 New collagen synthesis is also important for cell migration. In vitro, treatment of cells with collagen synthesis inhibitors prevented the formation of focal adhesions and the assembly of actin stress fibers, and attenuated SMC migration. 43 The deficits in migration persisted regardless of whether SMCs were plated on wells pre-coated with collagen types I, III, or IV, showing that the cells did not merely migrate across a pre-formed matrix, but modified the matrix by depositing new collagen. The types of newly synthesized collagens were not identified in this study, but it is tempting to speculate that type VIII collagen was one of them.
Type VIII collagen was expressed transiently and in coincidence with SMC migration during neointimal hyperplasia, 19 and we found that it stimulated the chemotaxis of SMCs in vitro. 26 SMCs adhere less strongly to type VIII collagen compared to type I collagen, a property which facilitates the translocation of cells across the substrate. 20, 26 Furthermore, plating SMCs on increasing concentrations of type VIII collagen increased the production of MMP-2 and MMP-9, which may also facilitate cell migration. 26 Using SMCs isolated from mice with targeted deletion of the genes for the α 1 and α 2 chains of type VIII collagen (type VIII collagennull), and comparing these to cells derived from wild-type littermate mice, we determined that type VIII collagen-null SMCs displayed decreased spreading, migration, and MMP-2 activity. 27 Importantly, SMCs which could not elaborate an endogenous type VIII collagen matrix could not overcome strong adhesion to a polymerized type I collagen matrix, and consequently cell spreading and migration were impaired. 27 Taken together, our data suggest that after arterial injury, SMCs deposit type VIII collagen masking the interstitial matrix in the vessel wall, and use the type VIII collagen as a provisional matrix to promote migration. A recent paper reports that type VIII collagen also mediates endothelial cell adhesion and spreading, and that adhesion of endothelial cells is accomplished via α 2 β 1 integrin binding to the amino acid sequence GLOGER located in the α 2 chain of type VIII collagen. 44 Given its important role in promoting migration, and increased expression after vascular injury, experiments are currently in progress studying the neointimal hyperplastic response in the injured arteries of the type VIII collagen-null mouse.
Collagen gel contraction mediated by SMCs grown within a 3-D collagen gel is frequently used as an in vitro assay to mimic the ECM remodeling which occurs in vivo, and the arterial contraction and inward remodeling that occurs in atherosclerosis and restenosis. Furthermore, gel contraction and cell migration are mediated by common mechanisms as cell contraction and transfer of intracellular force to the ECM is also required for cell translocation within the gel. Both α 1 β 1 integrins 33 and α 2 β 1 integrins 45 can mediate collagen gel contraction by SMCs. Li, et al. found that activation of the Rho-ROCK pathway is primarily responsible for SMC migration in and contraction of type I collagen gels, but PI3K, Rac and p38 MAPK pathways also contribute. 46 We have learned a great deal from these studies of SMC interactions with collagen; however, several important questions remain. Most studies have utilized simple in vitro systems exposing cells to exogenously applied collagen, usually in a 2-D confirmation. There is an urgent need for studies of cellular responses to complex, multi-component matrices, presented in the 3-D confirmation, or endogenously synthesized and deposited by the cells. Studies using cells from genetically targeted mice will be very useful in expanding our knowledge in these areas. It is clear that the compositional, biochemical and structural status of the matrix influences cellular responses in atherosclerosis. Therefore, careful attention must be given to the status of the matrix microenvironment when investigating the pathogenesis of disease.
Collagen regulation of inflammatory cells in atherosclerosis
One of the inciting events in atherosclerosis is the recruitment of monocytes from the circulation and their accumulation within the blood vessel wall. 47 Within the subendothelial space, monocytes differentiate into activated macrophages, which phagocytose lipids and secrete inflammatory cytokines and proteases, including MMPs, cathepsins and plasmin. Macrophage differentiation also involves a change in cell shape, from a round floating cell to a polarized cell capable of interacting with and migrating through the ECM microenvironment within the plaque.
Signals transmitted from collagen regulate all aspects of macrophage biology including differentiation, migration, inflammatory cytokine production and the elaboration of matrix degrading enzymes. These features of macrophage interactions with collagen are illustrated schematically in Figure 2 . The profound impact of collagen on monocyte/macrophage gene expression was demonstrated in a global gene expression screen of monocytes cultured on col-lagen, which revealed 896 differentially expressed gene fragments compared to cells cultured in suspension. Of these, 316 genes were specifically induced by adhesion to collagen and not fibronectin or laminin. 48 Studies of monocytes exposed to type I collagen have revealed important roles for this matrix molecule in stimulating cellular responses. Plating human peripheral blood mononuclear cells (PBMCs) on a type I collagen matrix resulted in increased differentiation and activation, as evidenced by increased cell spreading, and changes in cell surface marker expression, including decreased CD14 expression (part of the lipopolysaccharide receptor complex) and increased CD71 expression (the transferrin receptor). 49 Furthermore, adhesion to type I collagen increased macrophage phagocytic activity, 50 leading to the increased uptake of acetylated low-density lipoprotein (LDL). 49 Collagen stimulation also enhanced phorbol myristate acetate (PMA)-induced superoxide production by macrophages, and primed the secretion of arachidonic acid metabolites such as prostaglandin E2 and thromboxane B2. 51 Finally, type I collagen stimulated MMP-9 expression by PBMCs 49 and MMP-1 expression by alveolar macrophages in vitro. 52 Akin to the differences described above for SMCs, polymeric and monomeric type I collagen elicit different responses in macrophages. Lepidi and colleagues showed that human monocyte-derived macrophages plated on monomeric type I collagen spread more (a surrogate measure of differentiation) and increased their production of MMP-9, while plating cells on polymerized type I collagen inhibited spreading and MMP-9 production. 53 These studies indicate that macrophages are sensitive to the concentration and physical state of the collagen to which they are exposed, and future studies are required to precisely determine how the status of the matrix affects inflammatory cell responses. 
Leukocyte collagen receptors
The attachment of leukocytes to collagen is mediated by three types of collagen receptors: integrins (α 1 β 1 , α 2 β 1 ), DDRs, and class A scavenger receptors (SRA). Integrin α 2 β 1 is constitutively expressed on macrophages at low levels, 54 while α 1 β 1 expression is upregulated during macrophage activation. 55 Clustering β 1 integrins with antibodies results in the upregulation of mRNA expression for inflammatory cytokines such as tumor necrosis factor α (TNFα) and interleukin-1 (IL-1). 56, 57 However, a second signal such as lipopolysaccharide (LPS) is required for translation and secretion of these cytokines. 58 Thus, macrophage adhesion to collagen provides signals through integrins which synergize with other cues to promote differentiation and cytokine production.
A critical role for the leukocyte α 1 β 1 integrin in atherogenesis has been described in the apolipoprotein E-null mouse (ApoE-null), a mouse model of atherosclerotic plaque development. Mice made doubly deficient in the genes for integrin α 1 and apoE (α 1 -/-;apoE -/-) developed smaller plaques with a reduced content of macrophages and T cells compared to their α 1 +/+ ;apoE -/littermates, suggesting a role for α 1 integrin in mediating leukocyte invasion during atherogenesis. 59 Furthermore, tissue culture studies of bone marrow-derived macrophages from the α 1 -/-;apoE -/mice revealed that these cells exhibited impaired invasion of type IV collagen-coated membranes. 59 These results are consistent with other studies demonstrating reduced inflammatory cell accumulation after genetic deletion or antibody blockade of the α 1 β 1 receptor in experimental models of colitis, 60 renal fibrosis, 61 rheumatoid arthritis, and contact-and delayedtype hypersensitivity reactions. 62, 63 Taken together, these studies underscore the importance of collagen signaling through the α 1 β 1 integrin in regulating macrophage invasion of tissues during chronic inflammation.
Deletion of the α 2 integrin in ApoE-null mice did not affect atherosclerotic plaque formation, suggesting that this receptor is not required for atherosclerosis. 64 However, platelets adhere to collagen using this receptor, and indirectly stimulate PBMC spreading and MMP-9 secretion when the two cell types are cocultured. 65 Therefore, in cases involving atherosclerosis and a robust thrombotic response, the α 2 β 1 integrin may play an indirect role in inflammatory cell activation.
The class A scavenger receptors (SRAs) mediate macrophage adhesion to gelatin (collagenasedegraded or heat denatured collagen types I and III). 66, 67 The SRA also mediates adhesion to decorin, biglycan and glycated type IV collagen. SRAs regulate the uptake of modified LDL during atherosclerosis, and therefore they are key determi-nants of foam cell formation during atherogenesis. However, it is not clear whether there is a relationship between ECM binding and lipid uptake by SRAs. Furthermore, contradictory data on the importance of the SRA in mediating plaque growth arises from studies of ApoE-null mice with gene deletions for SRA, and may be related to the use of mice with different genetic backgrounds. [68] [69] [70] Recent research has shown that DDRs play important roles in the activation and differentiation of macrophages. DDR1 mRNA and protein was detected on cultured PBMCs and polymorphonuclear leukocytes (PMNs), and was upregulated by stimulation with IL-1, TNFα, and LPS. 71 DDR1 expression was also detected in vivo on leukocytes invading renal carcinomas. 71 The receptor regulates several macrophage functions important in inflammation, including the maturation and antigen presentation function of human monocyte-derived dendritic cells, 72 and nitric oxide production. 73 Two splice variants of DDR1 are expressed in PBMCs, DDR1a and DDR1b, and they mediate different responses. Overexpressing either variant in THP-1 cells (a macrophage cell line) led to increased cell adhesion to collagen. However, overexpression of DDR1a promoted invasion of these cells through collagen matrices, 71 while overexpression of DDR1b promoted cell differentiation and increased cytokine production via the activation of p38 and NFκB. 74, 75 Less is known about the function of DDR2; however, DDR2 was upregulated on mature bone marrow-derived dendritic cells, and promoted antigen uptake and presentation, and cytokine secretion. 76 Taken together, these studies support a role for collagen signaling through DDRs as a key mediator of macrophage and dendritic cell biology.
We have recently identified a critical role for DDR1 in inflammatory cell accumulation and fibrosis during atherogenesis. 31 Mice deficient in both DDR1 and the low-density lipoprotein receptor (Ddr1 -/-;Ldlr -/-) were fed a high-fat diet for up to 24 weeks to induce atherosclerosis. Deletion of DDR1 resulted in a persistent 60% reduction in atherosclerotic lesion burden compared to Ddr1 +/+ ; Ldlr -/control mice. The reduction in lesion size in Ddr1 -/-;Ldlr -/mice was correlated with reduced macrophage accumulation in the plaques and decreased mRNA expression of MCP-1 and VCAM-1, suggesting a potential role for DDR1 in macrophage recruitment into the atherosclerotic plaque. In addition, bone marrow-derived macrophages from Ddr1 -/-;Ldlr -/mice had reduced expression of MMPs 2, 9 and 14, suggesting that Ddr1 -/macrophages were unable to produce sufficient proteolytic activity to invade the plaque. A role for DDR1 in macrophage accumulation during chronic inflammation is supported by several studies that have investigated DDR1 expression and function in animal models of glomerulosclerosis and bleomycin-induced pulmonary fibrosis as well as in human idiopathic pulmonary fibrosis and sarcoidosis. [77] [78] [79] [80] [81] Elucidating the role of DDR1 in macrophage biology is an area ripe for future investigation which promises to be applicable to many inflammatory diseases.
New molecular imaging technologies allow investigators to visualize macrophage infiltration into the plaques of live animals. Radioactive tracers or magnetofluorescent nanoparticles are used to label macrophages in vitro, followed by adoptive transfer to syngeneic mice. Plaque macrophages are then imaged using a variety of techniques including micro-single-photon emission computed tomography (micro-SPECT), magnetic resonance imaging (MRI), and near infrared fluorescence (NIRF) microscopy. [82] [83] [84] NIRF microscopy has also been used to image proteolysis in the plaque by detecting the degradation of fluorescent substrates for the MMPs and cathepsins in atherosclerotic plaques in live mice. 85, 86 Investigators have used these methods to study plaque growth in mice, and plaque regression after statin treatment. Eventually these molecular imaging technologies will allow the early detection of inflammation in atherosclerotic plaques in humans, expand our understanding of cellular and molecular events in atherosclerosis, and permit non-invasive testing of the therapeutic efficacy of anti-inflammatory drugs.
Collagens and atherosclerotic complications
Collagens in the fibrous cap and susceptibility to plaque rupture Atherosclerotic plaques are covered by a cap rich in fibrillar collagens and elastin. The cap confers considerable stability to the plaque, protecting against rupture and the devastating complication of thrombosis. Rupture can also lead to the embolization of lipid fragments which results in the occlusion of downstream vessels. Plaque rupture is thought to be responsible for the majority of acute coronary syndromes, which in turn are the major causes of morbidity and mortality in coronary artery disease. 87, 88 MMPs secreted by macrophages and SMCs in the shoulder regions of the plaque degrade collagens in the fibrous cap rendering the plaque vulnerable to rupture. [89] [90] [91] [92] Fibrillar collagen monomers are cleaved into fragments that are ¼ and ¾ of the length of the native full-length molecules following cleavage at a bond between glycine and isoleucine by the collagenases (MMPs 1, 8, and 13 ). 93 Collagenase-cleaved collagen fragments rapidly denature into gelatin, which can be degraded by MMPs 2 and 9. Many studies have demonstrated overexpression of MMPs in human and experimental atheromata including MMPs 1, 2, 3, 7, 8, 9, 12, 13, 14, 16 and 17. 94 Rekhter, et al. demonstrated that hypercholesterolemia decreases the mechanical stability of the plaque by increasing MMP activity and reducing collagen content at the shoulders. 95 Moreover, this could be reversed by lipid-lowering therapy, either by reducing dietary intake of cholesterol 96 or by treatment with statins. 97 This section will summarize knowledge about the roles of MMPs in plaque progression, rupture and aneurysm formation.
MMPs in atherosclerotic plaque progression and fibrous cap formation
Much research has been focused on elucidating the complex roles that MMPs play in atherogenesis. They contribute to cellular infiltration of the plaques by clearing ECM barriers to migration, and they also regulate ECM accumulation which can impact upon plaque size. A number of studies have utilized MMP gene deletion or overexpression in the ApoEnull mouse model of atherosclerosis and they have shown that while some MMPs are pro-atherogenic, others are anti-atherogenic, and the deletion of other MMPs has no effect on plaque size. Three recent studies have established a pro-atherogenic role for MMP-9 using three different models of murine atherosclerosis, all based on the ApoE-null mouse background. Deletion of MMP-9 resulted in decreased plaque volume, although there were discrepancies between studies as to whether SMC or macrophage infiltration into the plaques was affected by proteinase deficiency. [98] [99] [100] Deletion of MMP-2 in the ApoE-null mouse resulted in decreased plaque size, concomitant with the decreased accumulation of SMCs and macrophages in the plaque. 101 Thus, MMP-2 and MMP-9 have been identified as proatherogenic MMPs mediating the migration of both SMCs and inflammatory cells in the atherosclerotic plaque. By contrast, mice with a combined deficiency in MMP-3 and ApoE developed larger plaques with more collagen compared to MMP-3 +/+ littermates. 102 Lemaitre, et al. addressed the role of MMP-1 in plaque formation and rupture by overexpressing human MMP-1 in mouse macrophages. 103 This caused a decrease in atherosclerotic plaque size compared to littermate controls and a decrease in collagen accumulation, and suggested a protective role for MMP-1 in plaque development. These two studies indicated atheroprotective roles for MMP-1 and MMP-3 which were related to their ability to prevent plaque expansion through excessive matrix accumulation. Accumulation of SMCs and macrophages within the plaques was either not changed (MMP-1 overexpressors) or actually decreased (MMP-3-null). Targeted deletion of either MMP-12 or MMP-13 in the ApoE-null mouse had no effect on plaque size, nor on the cellular composition of the plaques. 100, 104 However, there were increases in fibrillar collagen content, and fibril size and alignment in the fibrous caps of the MMP-13-null mice. 104 The latter observation is not surprising, considering that MMP-13 functions as a principle collagenase in the mouse. Fukumoto and colleagues showed similar results studying atherosclerosis in mice made resistant to collagen degradation by a mutation of the collagenase cleavage site in type I collagen (ColR/R mice). They found no change in plaque size, but increased accumulation of collagen in plaques of the ColR/R mice. 105 In these studies, the authors linked the preservation of collagen in the fibrous cap to plaque stability, although plaque rupture was not directly measured.
The tissue inhibitors of metalloproteinases (TIMPs) are endogenous regulators of the MMPs and the functions of TIMPs have also been studied by gene deletion or systemic adenoviral expression in ApoE-null mice. Two studies using systemic injections of adenovirus to overexpress TIMP-1 reported conflicting results, either having no effect on plaque size in the aorta, 106 or decreasing plaque size in the brachiocephalic artery. 107 The differences in results could be due to the different vascular sites examined, or differences in the expression level of TIMP-1. When transgenic mice overexpressing TIMP-1 were cross-bred with ApoE-null mice, there was no difference in lesion area compared to ApoE-null controls. 108 Two independent studies of mice with targeted deletion of TIMP-1 on the ApoE-null background also report contradictory results; plaque formation was either decreased 109 or not changed. 110 By contrast, overexpression of TIMP-2 by systemic injection of adenovirus inhibited plaque growth by decreasing macrophage invasion; however, SMC number and collagen and elastin content were increased. 106 Taken together, these studies suggest that each MMP has a distinct role in plaque formation, whether it be permitting plaque growth by facilitating cellular migration into the intima, or preventing the excessive accumulation of ECM. Similarly, the functions of the TIMPs cannot be generalized, and may depend upon the expression level of a particular TIMP, and the panel of MMPs that each TIMP inhibits.
MMPs and plaque rupture
It is clear that MMPs and TIMPs play important roles in plaque development, but fewer studies have addressed their roles in plaque rupture. Williams and colleagues developed a model of rupture by feeding ApoE-null mice a high-fat diet rich in lard, and they examined the plaques that developed in the brachiocephalic artery which underwent repeated rupture and fibrotic healing events. 111 This resulted in the formation of buried fibrous caps which were counted to assess the frequency of rupture. Deletion of MMP-12 resulted in a decrease in the number of buried fibrous caps, while deletion of MMP-3 and 9 actually increased the number of caps, and deletion of MMP-7 had no effect. 112 The authors concluded that MMP-12 was a mediator of rupture, while MMP-3 and 9 protected against rupture. However, the results of two other studies which overexpressed MMP-9 specifically in the atherosclerotic plaque were quite different. Expressing active MMP-9 in macrophages, Gough and colleagues showed an increased incidence of rupture in the brachiocephalic artery and aortic arch plaques of ApoE-null mice. 113 De Nooijer and colleagues used intraluminal transfection with adenovirus to overexpress MMP-9 in carotid artery plaques of ApoE-null mice, and found that this led to increased intraplaque hemorrhage, and thinning of the fibrous cap, both features of plaque rupture. 114 Thus, the results appear to differ depending on whether endogenous MMP-9 is deleted, 112 or exogenous MMP-9 is overexpressed in the lesions. 113, 114 Overexpressing either TIMP-1 or TIMP-2 by systemic injection of adenovirus, Johnson and colleagues showed that TIMP-2 but not TIMP-1 inhibited plaque rupture. 106 A limitation of most of these studies is that rupture was reported at only one location in the arterial system, and it is not certain whether similar rupture events occur elsewhere. In the human, clinically significant plaque disruption occurs in the coronary arteries and carotids, and thus far no naturally occurring mouse model can mimic this specific localization. Furthermore, the long-term complications of plaque rupture in humans, namely fatal myocardial ischemia and stroke, are not well represented in the mouse.
MMPs and aneurysm formation
Another important complication of atherosclerosis in the abdominal aorta is aneurysm formation, which has been linked to inflammation and MMP activity in the vessel wall underlying the plaques. The incidence of elastic lamina destruction is commonly used as an index of wall disruption, as is the measurement of aortic dilatation. Deletion of MMP-3, MMP-9, or MMP-12 in the ApoE-null mouse result in a decrease in aneurysm formation. 100, 102 Consistent with this, overexpression of MMP-12 in a transgenic rabbit fed a highfat diet led to accelerated plaque formation and increased the incidence of aneurysm formation. 115 Deletion of TIMP-1 results in increased incidence of aneurysms due to unopposed proteolytic activity in the vessel wall. 109, 110 Taken together, these data support important roles for MMPs 3, 9, and 12 in aneurysm formation, and a role for TIMP-1 in protecting against aneurysms.
It is clear from our emerging knowledge that the functions of MMPs in atherosclerosis are complex. In general, looking at the data obtained from many studies of MMP-manipulated transgenic mice, the MMPs can be subdivided into categories based on their dominant pathophysiologic roles in atherosclerotic vascular disease. (1) MMPs which promote plaque expansion by facilitating SMC or inflammatory cell infiltration into the plaque (MMPs 2, 9). (2) MMPs which are anti-atherogenic and mount compensatory degradation responses to prevent excessive matrix accumulation in the plaque (MMPs 3, 13). (3) MMPs which mediate collagen degradation in the fibrous cap and therefore plaque rupture (MMPs 12 and 9). (4) MMPs which degrade matrix and allow disruption of underlying elastic lamellae and collagen leading to aneurysmal dilatation (MMPs 3, 9, 12). However, since many MMPs act co-operatively to digest and remodel the heterogeneous ECM, genetic deletion of individual MMPs or TIMPs may not be the most appropriate method for evaluating the role of this protease network in atherogenesis. It is important also to remember that the functions of the MMPs go beyond merely degrading the ECM. These enzymes also release growth factors from the matrix, and activate various growth factors and cytokines. As such, the role of MMPs is likely to be multi-faceted, and further investigation is required.
Given their important roles in many aspects of atherogenesis, it is not surprising that attention has been paid to the use of MMPs/TIMPs as circulating biomarkers of the status of the atherosclerotic plaque in humans. Circulating MMP-9 is increased in the presence of stable angiographic atherosclerosis, after rapid lumen reduction or fatal events, and is also increased in conditions associated with atherosclerosis such as diabetes and hypertension. TIMP-1 levels in the circulation are elevated with stable atherosclerosis in the coronary, carotid and peripheral arteries. 116 These studies show some promise for the detection of atherosclerosis and vulnerable plaque in patients, although there are limitations in that the biomarkers are not tissue-specific, and therefore circulating levels may not be correlated with the amount of marker present in tissue (particularly for MMPs, which bind to the ECM and are retained in the tissue).
Atherosclerotic calcification
Mineralization of the intima (intimal or atherosclerotic calcification) can be a feature of advanced atherosclerotic lesions. 117 Intimal and medial calci-fication proceed via distinct mechanisms, affect unique patient populations and present different clinical ramifications. 118 Histologically, intimal calcification is observed as hydroxyapatite crystals originating from secreted matrix vesicles in the vicinity of the lipid rich necrotic core and in close proximity to cellular debris and inflammatory cell infiltrate. 117, 119, 120 Since hydroxyapatite crystals are propagated along extracellular matrix fibers, the composition of the extracellular matrix has a profound effect in regulating this process, and collagens, which are abundant in atherosclerotic lesions, are likely to contribute to intimal calcification.
At the cellular level, mineralization of the intima is believed to recapitulate the process of endochondral ossification, through the elaboration of a chondrogenic transcriptional program and early evidence of chondrocyte-like cells within the intima propelled the search for biochemical markers of this lineage in atherosclerotic lesions. Over the past decade, immunohistochemical and quantitative realtime polymerase chain reaction (PCR) techniques have been used to demonstrate the expression of type II collagen, Sox-9, and alkaline phosphatase (ALP) (genes normally restricted to chondrocytes) in atherosclerotic lesions of humans 121, 122 as well as atherosclerosis-susceptible ApoE-null mice. In these mice, intimal calcification is evident in atherosclerotic lesions of the aortic arch, the aorta, the pulmonary arteries, and the brachiocephalic arteries. 121, [123] [124] [125] LDLR-null mice fed a high-fat diet also develop intimal calcification in the proximal aorta, although this model is currently underutilized for the investigation of intimal calcification. 126, 127 Cellular mediators of calcification Vascular calcification is an active cell-driven process which, in the context of atherosclerosis, may be orchestrated by differentiated intimal cells (SMCs or macrophages) or undifferentiated progenitor cells, either resident within the vessel wall or derived from the circulation. Although macrophages have been noted adjacent to foci of calcification, 128 there is little evidence for macrophage-driven intimal calcification. Rather, they are potential sources of proatherogenic factors such as cytokines and reactive oxygen species, which appear to exacerbate calcification in a paracrine manner. 129 Towler and colleagues have illustrated the osteogenic potential of adventitial aortic myofibroblasts in Ldlr -/mice. 130, 131 Similarly, Bostrom and colleagues have demonstrated that colonies of cells (termed calcifying vascular cells or CVCs) explanted from bovine aortic media are capable of spontaneous phenotypic transition to an osteoblastic or chondrogenic phenotype. 132, 133 Whether these CVCs represent undifferentiated progenitor cells, as originally suggested by Tintut and colleagues, or dedifferentiated medial SMCs remains to be determined. CVCs do express markers of mesenchymal stem cells (CD29 and CD44); however, more recent work by Bobryshev and colleagues suggests that intimal SMCs are capable of transdifferentiation into chondrocytes in vivo, 121 providing evidence that calcifying intimal cells may arise from differentiated SMCs, in addition to a resident progenitor cell population. At the present time, the role of circulating progenitor cells in populating atherosclerotic lesions remains highly debated and further studies are required to determine whether they too participate in intimal calcification.
Collagens provide a permissive matrix for calcification
One of the dominant themes in studies of vascular calcification is that this process requires a permissive matrix. Bone matrix proteins such as osteocalcin, osteopontin, bone sialoprotein, and collagen types II and IX can be expressed by SMCs. [134] [135] [136] Roles have been established for several noncollagenous matrix proteins in promoting (e.g. fibronectin, 137 elastin degradation products, elastin precursors, 138, 139 and decorin 140 ) or inhibiting (e.g. matrix gla protein-1, 141,142 and osteopontin 143 ) this process. Collagens have received little attention thus far, although some evidence suggests that collagens are important regulators of CVC-mediated calcification.
Watson and colleagues reported that calcifying CVCs in vitro produced an ECM rich in type I collagen and that exposure to type I collagen stimulated robust calcification by otherwise slowlymineralizing cells. This effect was specific to type I collagen, as exposure to type IV collagen inhibited CVC formation. 137 A similar requirement for threedimensional type I collagen in chondrocyte cultures suggests that this fibrillar collagen, in the context of atherosclerosis, may be involved in commitment of intimal cells to the chondrogenic lineage. 144 Type II collagen, the production of which is normally restricted to chondrocytes, is also evident in calcifying intimal lesions. 121, 124 In chondrocyte cultures 145 and developing bone, 146 type II collagen is essential for chondrocyte maturation and the presence of type II collagen surrounding chondrocyte-like cells in atherosclerotic plaques suggests a similar mechanism in intimal calcification, although this remains to be directly investigated.
The mechanisms by which different types of collagen mediate their effects on intimal calcification are largely undefined; an issue that is complicated by overlapping affinities of the collagen receptors for various collagen subtypes. Schapira and collea-gues recently demonstrated that genetic deletion of the integrin subunit α 1 in ApoE-null mice increased the extent of cartilaginous metaplasia in intimal lesions. 59 Taken together with earlier findings from Watson and colleagues, 137 this may explain how type IV collagen (the preferred ligand for α 1 β 1 ) inhibits CVC formation in vitro. This finding also implies that type I and type II collagens, which seem to promote mineralization, are unlikely to use the α 1 β 1 receptor to mediate these effects, but rather, they may utilize other integrin combinations, such as α 2 β 1 , α 10 β 1 or the DDRs. In favor of this generalization, deficiencies in α 10 , β 1 , or DDR2 have been shown to hinder chondrocyte maturation and matrix mineralization in calcifying bones, [147] [148] [149] although it is not known whether similar mechanisms are at play in vascular calcification.
In addition to regulating cell differentiation and maturation, collagen interactions with their cognate receptors provide outside-in signaling that has the potential to feedback and affect the ECM environment. Type II collagen binding to DDR2, for example, stimulates the expression of MMP-13, 150 an important collagenase involved in atherosclerosis. In turn, MMP-13-mediated proteolysis of type II collagen reveals a cryptic sequence which drives chondrocytes into the mineralization-competent state of hypertrophy. 151 Thus, it is tempting to speculate a mechanism where the expression of type II collagen in the intima can induce a feed-forward matrix remodeling mechanism to drive the process of atherosclerotic calcification. In human atherosclerotic lesions, the endogenous MMP inhibitor, TIMP-1, is highly expressed adjacent to calcified foci, 152 further alluding to a role for the MMP family in the calcification process. Whether MMPs can be targeted to prevent calcification of the atherosclerotic intima remains to be tested, although broad-spectrum MMP inhibition with doxycycline successfully prevented vitamin D-induced calcification of the media in rats. 153 
Clinical perspectives on vascular calcification
Vascular calcification is readily detected with current imaging technologies. 154 Using electron beam computed tomography, intimal calcification has been reported to affect at least one third of women and half of men over the age of 45. 155 By the age of 70, nearly all patients show some evidence of vascular calcification 156 and the presence of calcification in the coronary arteries, 157, 158 or the aortic arch 159 predicts a two to eightfold increase in the risk of coronary events. Intimal calcification is believed to affect plaque mechanics and susceptibility to rupture, although this issue remains highly controversial. Based on the theory that plaques are most prone to rupture at the interface between tissues of high and low densities, Abedin and colleagues have proposed a biphasic risk model for rupture associated with calcification. This model suggests that since calcified regions have higher density than non-calcified regions and the initial foci of calcification may be numerous, early calcification may produce many interfaces between high-and low-density tissues, increasing the risk of rupture. However, as the disease progresses, individual foci of mineralization merge, decreasing the number of interfaces and lowering the risk of rupture. 160 In contrast to this model, a recent in vitro study using CVCs demonstrated that highly calcified CVC nodules were not any more vulnerable to shear stresses than less calcified nodules, although the mechanical stability of the atherosclerotic intima may not be well recapitulated in this single-cell type culture model. 161 Studies using organ explant cultures are probably more useful tools to study calcified intimal lesions and their responses to hemodynamic stresses. Huang and colleagues investigated the mechanical properties of post-mortem plaque specimens and found that coronary artery calcification did not affect internal plaque stresses. 162 Despite these findings, a growing body of evidence suggests that calcification reduces the stability of the atherosclerotic lesion. Fitzgerald and colleagues demonstrated a strong correlation between calcification and dissection after balloon angioplasty. 163 In this light, it is important to consider that plaque stability in zones of calcification may also be related to MMP activity and matrix remodeling, which are known to reduce lesion stability in the shoulder regions. Further investigations are required to precisely define the role of calcification in plaque stability, which will hopefully include more detailed analyses of the activities of proteolytic enzymes as well as the collagen metabolism in these discrete regions of advanced lesions.
Conclusions
Our understanding of the role of collagen molecules in the initiation and progression of atherosclerosis is expanding at an increasing rate. Once thought to be biologically inert, collagens are now known to be bioactive components of the ECM which interact with and exert profound effects on many cell types within the vessel wall. Moreover, it has become evident that these effects are heavily dependent on the geometric organization of collagen molecules within the ECM (2-D, 3-D, soluble, fibrillar), and not simply their relative abundance, a generalization that will prompt future studies to investigate how cells respond to more complex matrix microenvironments. In addition to their biological activities, col-lagens are indeed critical structural components of both the healthy and diseased vessel. Yet despite their strength, collagens are highly vulnerable to proteolytic digestion, remodeling and mineralization, complications which mark advances in the severity of atherosclerosis and increases in the risk of detrimental clinical events. While we have made advances in understanding how collagens regulate atherogenesis, there is still much to be learned and several avenues of research remain largely unexplored. Future studies are likely to test the roles of collagens in the infiltration of circulating stem cells or precursor cells and the roles of collagens in the initiation and propagation of plaque calcification. Moreover, they are likely to target clusters of genes (for example MMPs), rather than individual genes which may demonstrate overlapping functions. Combined with innovative investigative techniques such as molecular imaging to study in vivo collagen dynamics, these studies promise to reveal novel roles for collagens and their receptors in atherogenesis.
